Trademark: 87126222
Status Date
Thursday, March 7, 2024
Registration Number
5318216
Registration Date
Tuesday, October 24, 2017
Filing Date
Wednesday, August 3, 2016
Published for Opposition
Tuesday, December 27, 2016
42 Pharmaceutical drug identification and development services; pharmaceutical drug development services in the field of neurological disorders
Mar 7, 2024
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Mar 7, 2024
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Mar 7, 2024
Case Assigned To Post Registration Paralegal
Sep 15, 2023
Teas Section 8 & 15 Received
Oct 24, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 24, 2017
Registered-Principal Register
Sep 21, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 20, 2017
Allowed Principal Register - Sou Accepted
Sep 5, 2017
Statement Of Use Processing Complete
Aug 15, 2017
Use Amendment Filed
Sep 2, 2017
Case Assigned To Intent To Use Paralegal
Aug 15, 2017
Teas Statement Of Use Received
Aug 16, 2017
Notice Of Approval Of Extension Request E-Mailed
Aug 14, 2017
Sou Extension 1 Granted
Aug 14, 2017
Sou Extension 1 Filed
Aug 14, 2017
Sou Teas Extension Received
Feb 21, 2017
Noa E-Mailed - Sou Required From Applicant
Dec 27, 2016
Official Gazette Publication Confirmation E-Mailed
Dec 27, 2016
Published For Opposition
Dec 7, 2016
Notification Of Notice Of Publication E-Mailed
Nov 15, 2016
Approved For Pub - Principal Register
Nov 14, 2016
Assigned To Examiner
Aug 8, 2016
New Application Office Supplied Data Entered
Aug 6, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
